Co-Stimulation Through 4-1bb/Cd137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy

PLoS ONE - United States
doi 10.1371/journal.pone.0060031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Efficacy of Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2012English

Minimally Invasive Liver Resection to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in Patients With Metastatic Melanoma

World Journal of Surgical Oncology
SurgeryOncology
2012English

CTLA-4 Blockade Boosts the Expansion of Tumor-Reactive CD8+ Tumor-Infiltrating Lymphocytes in Ovarian Cancer

Scientific Reports
Multidisciplinary
2020English

Analysis of T Cell Receptor Variability in Tumor-Infiltrating Lymphocytes From a Human Regressive Melanoma. Evidence for in Situ T Cell Clonal Expansion.

Journal of Clinical Investigation
Medicine
1993English

Tumor-Infiltrating Lymphocytes in Melanoma

Current Oncology Reports
Oncology
2012English

Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Antibodies to Costimulatory Receptor 4-1bb Enhance Anti-Tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Immunity
Infectious DiseasesAllergyImmunology
2018English

Tumor Necrosis Factor Receptor Superfamily Member 9 (TNFRSF9; 4-1bb; CD137)

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy